AI CuratorAI-generated
Research summary · AI summary · not yet reviewedHuman studyInterventionalTrial registry record – peer review not applicable
Interventional Study of Virtual Reality Stimulation in People with Multiple Sclerosis
An interventional study was planned to enroll 30 participants aged 18 to 65 with Multiple Sclerosis. The study design included two groups receiving either Virtual Reality Gamma Sensory Stimulation or a Sham version, with the primary outcome measuring changes in fatigue impact (MFIS) over a follow-up period.
- Tags
- #Other
- Most relevant to
- —
- Source
- Read original source
This plain-English summary was written by AI from a trial registry record and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- No results yet
- Outcome
- Ongoing – no results yet
Why it matters
This study aims to explore a new intervention for managing fatigue in Multiple Sclerosis, a common and debilitating symptom for patients.
What this does not prove
No results are posted; planned enrollment and endpoints do not constitute findings.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Interventional
- Participants / samples
- 30 · planned enrolment
- Randomised
- Yes
- Controlled
- Yes
- Primary endpoint met
- Not reported
- Relevant MS type
- All
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- People with Multiple Sclerosis; ages from 18 to 65 years
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
Supporting passages (18)
study phasePhase: Not applicable
study designStudy type: Interventional
subjectsParticipants: people; ages from 18 Years to 65 Years; sex All
sample sizeEnrollment: 30 participants (estimated)
randomizedAllocation: Randomized
controlledIntervention model: Parallel
relevant ms typesConditions: Multiple Sclerosis
interventionInterventions: Virtual Reality Gamma Sensory Stimulation; Virtual Reality Sham Sensory Stimulation
comparatorArm types: Active comparator; Sham comparator
primary endpointPrimary endpoints: Change in Modified Fatigue Impact Scale (MFIS) total score
follow upFollow-up: Baseline to End of Treatment (week 4); Baseline to Follow-up (week 8); Baseline to End of Treatment (week 4) and Follow-up (week 8); Baseline through End of treatment (week 4)
limitationsNo results are posted. Planned enrolment and endpoints are not findings.
populationParticipants: people; ages from 18 Years to 65 Years; sex All
outcome"status": "RECRUITING",
findingsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
peer reviewedTrial registry record.
controlledArm types: Active comparator; Sham comparator
sample size basisEnrollment: 30 participants (estimated)
AI assessment, not yet reviewed by a person · version 2 · Community votes are separate from evidence review.